NIKA — NIKA PHARMACEUTICALS, INC

—
OTC · Health Care · Pharmaceuticals · CIK 1145604 ·
Last close
$0.35
Market Cap
$369.14M
52W High
$0.98
52W Low
$0.20
ADV30
153
Next earnings
—
Nika Pharmaceuticals, Inc. engages in the development and distribution pharmaceutical products for dietary supplements and antiviral drugs in the United States. The company offers ITV-1, TNG, physiolong, carotilen, fructin, dry boza, anthocylen C, hypocholestin, biodetoxin, silymaron, and solamentum products. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -13,023 -13,023 5,309 352 349,014
Jun 2026 0 — -19,694 -19,694 9,942 2,932 340,624
Mar 2026 0 — -13,359 -13,359 20,637 1,530 331,624
Dec 2025 0 — -37,088 -37,089 20,996 1,889 318,624

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-70,785
Investing CF
$0
Financing CF
$64,850
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-9,050,086
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-83,164
Pretax Income TTM
$-83,165
Interest Exp TTM
—
Analysts
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -76,398 -76,398 20,996 318,624 -297,628 -79,654
Dec 2024 0 -95,792 -95,792 17,934 239,164 -221,230 -154,932
Dec 2023 0 -64,833 -64,833 19,596 101,745 -82,149 -64,833
Dec 2022 0 -3,183,715 -3,183,715 864 18,180 -17,316 -33,715

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-78,125
OpCashFlow TTM
—
Assets (Latest)
$9,942
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
PBYI PUMA BIOTECHNOLOGY, INC. $369.13M $7.14 —
SPRY ARS Pharmaceuticals, Inc. $366.93M $3.65 —
CRMD CorMedix Inc. $371.44M $4.67 —
CYDY CytoDyn Inc. $366.64M $0.25 —
PEPG PepGen Inc. $365.73M $3.88 —

News headlines (Yahoo Finance, 1h cache)

Nika Pharmaceuticals, Inc. (OTCQB: NIKA) Funding Update
2026-08-25 14:13 · Yahoo
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) June 2026 Update
2026-06-04 14:10 · Yahoo
Nika Pharmaceuticals, Inc. (NIKA) Signed a Consultancy Agreement with MD Global Partners LLC
2026-03-06 16:58 · Yahoo
Nika Pharmaceuticals, Inc. (NIKA) Progress Update
2025-12-03 16:58 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.